A treatment of psoriasis was associated with a significantly reduced risk for heart attack compared with other forms of treatment, U.S. researchers say. Dr. Jashin J. Wu, director of dermatology research at Kaiser Permanente Los Angeles Medical Center, said tumor necrosis factor inhibitors are used as a treatment for psoriasis to block the inflammatory response of the disease. Wu and colleagues at the medical center conducted a retrospective study, using patient files, with at least three diagnosis codes for psoriasis or psoriatic arthritis, without previous heart attacks, from January 2004 to November 2010. Of the 8,845 patients included in the study, 57.4 percent were not treated with any systemic therapy or phototherapy (topical treatment group), 18.9 percent received a tumor necrosis factor inhibitor for at least two consecutive months (tumor necrosis factor inhibitor treatment group) and 23.7 percent were treated with oral systemic agents or phototherapy (oral/phototherapy treatment group). The study, published online in the journal Archives of Dermatology, found after adjusting for other heart attack risk factors, patients in the tumor necrosis factor inhibitor treatment group had a 50 percent reduced risk of heart attack and the oral/phototherapy treatment group had a 46 percent reduced risk of heart attack compared with patients in the topical treatment group.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor